Sugi Predict

Sugi Predict / Compounds / SCHEMBL25802412

SCHEMBL25802412

SCHEMBL25802412

c1ccc(-c2ccc(N(c3ccc(-c4ccccc4)cc3)c3ccc(-c4ccccc4)c4c3oc3ccccc34)cc2)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CDC14B O60729 3/20 0.42
▸ CDC14A Q9UNH5 3/20 0.42
▸ MAPT P10636 3/20 0.35
▸ MEN1 O00255 1/20 0.35
▸ CSF1R P07333 1/20 0.35
▸ PDGFRB P09619 1/20 0.35
▸ KIT P10721 1/20 0.35
▸ FLT3 P36888 1/20 0.35
▸ KMT2A Q03164 1/20 0.35
▸ HDAC6 Q9UBN7 1/20 0.35
▸ CYP19A1 P11511 2/20 0.34
▸ CYP17A1 P05093 1/20 0.34
▸ CYP11B1 P15538 1/20 0.34
▸ CYP11B2 P19099 1/20 0.34
▸ PLA2G2A P14555 3/20 0.33
▸ PLA2G4A P47712 3/20 0.33
▸ ALOX5 P09917 2/20 0.33
▸ KDM4E B2RXH2 2/20 0.33
▸ ALDH1A1 P00352 1/20 0.33
▸ POLB P06746 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24370357 0.96 CDC14B (0.41) CDC14BCDC14AMAPTMEN1CSF1R
SCHEMBL23046696 0.95 CDC14B (0.39) CDC14BCDC14AMAPTMEN1CSF1R
SCHEMBL23046790 0.93 ALOX5 (0.45) CDC14BCDC14AMAPTMEN1CSF1R
SCHEMBL24370380 0.92 CDC14B (0.41) CDC14BCDC14AMAPTMEN1CSF1R
SCHEMBL23046697 0.92 CDC14B (0.37) CDC14BCDC14AMAPTMEN1KMT2A
SCHEMBL23046695 0.92 PLA2G2A (0.39) CDC14BCDC14AMAPTMEN1KMT2A
SCHEMBL23046690 0.91 CDC14B (0.38) CDC14BCDC14AMAPTMEN1CSF1R
SCHEMBL23046688 0.90 PLA2G2A (0.37) CDC14BCDC14AMAPTMEN1CSF1R
SCHEMBL23046687 0.90 ALOX5 (0.37) CDC14BCDC14AMAPTMEN1CSF1R
SCHEMBL25551154 0.90 CDC14B (0.38) CDC14BCDC14AMAPTHDAC6ALOX5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230292599-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, AND COMPOSITION FOR ORGANIC MATERIAL LAYER OF ORGANIC LIGHT-EMITTING DEVICE LT MATERIALS CO.,LTD. (KR) 2023-09-14 — — US disclosed
US-20230292599-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, AND COMPOSITION FOR ORGANIC MATERIAL LAYER OF ORGANIC LIGHT-EMITTING DEVICE LT MATERIALS CO.,LTD. (KR) 2023-09-14 — — US disclosed
EP-4201930-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, AND COMPOSITION FOR ORGANIC MATERIAL LAYER OF ORGANIC LIGHT-EMITTING DEVICE LT Materials Co., Ltd. (KR) 2023-06-28 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230292599-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, AND COMPOSITION FOR ORGANIC MATERIAL LAYER OF ORGANIC LIGHT-EMITTING DEVICE CRY1, PPOX, ORC3 CDC14B 2445/4885CDC14A 2152/4885MAPT 376/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.